Browse our anti-HLA-A (HLA-A) Antibodies

Full name:
anti-Major Histocompatibility Complex, Class I, A Antibodies (HLA-A)
On www.antibodies-online.com are 173 Major Histocompatibility Complex, Class I, A (HLA-A) Antibodies from 20 different suppliers available. Additionally we are shipping HLA-A Proteins (44) and HLA-A Kits (5) and many more products for this protein. A total of 228 HLA-A products are currently listed.
Synonyms:
HLAA
list all antibodies Gene Name GeneID UniProt
HLA-A 3105 P30443 , P04439
HLA-A    
HLA-A    

Show all species

Show all synonyms

Most Popular Reactivities for anti-HLA-A (HLA-A) Antibodies

Select your species and application

anti-Human HLA-A Antibodies:

anti-Mouse (Murine) HLA-A Antibodies:

anti-Rat (Rattus) HLA-A Antibodies:

All available anti-HLA-A Antibodies

Go to our pre-filtered search.

Top referenced anti-HLA-A Antibodies

  1. Human Monoclonal HLA-A Primary Antibody for FACS, ICFC - ABIN2659031 : Nicodemus, Wang, Lucas, Varghese, Berek: Toll-like receptor-3 as a target to enhance bioactivity of cancer immunotherapy. in American journal of obstetrics and gynecology 2010 (PubMed)
    Show all 10 references for 2659031

  2. Human Monoclonal HLA-A Primary Antibody for FACS - ABIN2657515 : Darrow, Slingluff, Seigler: The role of HLA class I antigens in recognition of melanoma cells by tumor-specific cytotoxic T lymphocytes. Evidence for shared tumor antigens. in Journal of immunology (Baltimore, Md. : 1950) 1989 (PubMed)
    Show all 9 references for 2657515

  3. Human Monoclonal HLA-A Primary Antibody for FACS - ABIN2657919 : Ayyoub, Taub, Keohan, Hesdorffer, Metthez, Memeo, Mansukhani, Hibshoosh, Hesdorffer, Valmori: The frequent expression of cancer/testis antigens provides opportunities for immunotherapeutic targeting of sarcoma. in Cancer immunity 2004 (PubMed)
    Show all 9 references for 2657919

  4. Human Monoclonal HLA-A Primary Antibody for FACS, IF - ABIN2663732 : Barbatis, Woods, Morton, Fleming, McMichael, McGee: Immunohistochemical analysis of HLA (A, B, C) antigens in liver disease using a monoclonal antibody. in Gut 1982 (PubMed)
    Show all 9 references for 2663732

  5. Human Monoclonal HLA-A Primary Antibody for FACS, ICFC - ABIN2658757 : De Felice, Turco, Costanzo, Corbo, Ferrone, Venuta: Inhibition by anti-HLA class I mAb of IL-2 and IL-2 receptor synthesis in lymphocytes stimulated with PHA-P. in Cellular immunology 1990 (PubMed)
    Show all 9 references for 2658757

  6. Human Monoclonal HLA-A Primary Antibody for FACS - ABIN2661910 : Fayen, Huang, Ferrone, Tykocinski: Negative signaling by anti-HLA class I antibodies is dependent upon two triggering events. in International immunology 1998 (PubMed)
    Show all 9 references for 2661910

  7. Human Monoclonal HLA-A Primary Antibody for FACS, IP - ABIN2662341 : Geppert, Wacholtz, Patel, Lightfoot, Lipsky: Activation of human T cell clones and Jurkat cells by cross-linking class I MHC molecules. in Journal of immunology (Baltimore, Md. : 1950) 1989 (PubMed)
    Show all 9 references for 2662341

  8. Human Monoclonal HLA-A Primary Antibody for FACS - ABIN4900774 : Loubaki, Chabot, Bazin: Involvement of the TNF-α/TGF-β/IDO axis in IVIg-induced immune tolerance. in Cytokine 2015 (PubMed)
    Show all 2 references for 4900774

  9. Mouse (Murine) Polyclonal HLA-A Primary Antibody for IHC, WB - ABIN3023100 : Parham, Lomen, Lawlor, Ways, Holmes, Coppin, Salter, Wan, Ennis: Nature of polymorphism in HLA-A, -B, and -C molecules. in Proceedings of the National Academy of Sciences of the United States of America 1988 (PubMed)
    Show all 2 references for 3023100

More Antibodies against HLA-A Interaction Partners

Human Major Histocompatibility Complex, Class I, A (HLA-A) interaction partners

  1. Data suggest that only a small fraction of HLA-A*02:01- (HA)-binding ESO peptides are immunogenic, namely those that have high peptide-binding strength and peptide/HA complex stability. This study involved comparison of in silico-predicted and observed cytotoxic T-lymphocyte recognition of tumor antigen epitopes in melanoma patients and transgenic/knockout mice. (ESO = tumor antigen NY-ESO-1 (show CTAG1B Antibodies))

  2. The safety, the overall survival (OS), and the immunological responses based on an ELISPOT assay were determined to assess differences in patients who were HLA-A24 (show CD164 Antibodies)-positive [24(+)] and HLA-A24 (show CD164 Antibodies)-negative [24(-)].

  3. Here we define the nature and extent of the variation in 3,489 HLA-A, 4,356 HLA-B and 3,111 HLA-C alleles. The common alleles of human populations comprise 42 core alleles, which represent all selected polymorphism, and recombinants that have assorted this polymorphism

  4. It was shown that the HLA-A*34 allele is a risk factor for recurrent spontaneous abortion, while the HLA-A*24 and HLA-B*35 alleles are associated with protection, and no allele of the DRB1 (show RBM45 Antibodies) locus was associated with recurrent spontaneous abortion

  5. HLA-A alleles were not associated with predisposition to cutaneous leishmaniasis.

  6. a significant level of epitope-specific T cells could be detected ex vivo in peripheral blood mononuclear cells from active TB patients by an HLA-A*11:01 dextramer carrying the peptide Rv3130c194-204.

  7. In conclusion, our results confirm that the alleles HLA-A*02 and HLA-DRB1 (show HLA-DRB1 Antibodies)*07 are associated with the pathogenesis of vitiligo (show MITF Antibodies) in the Brazilian population. We demonstrated that allele HLA-A*32 is associated with susceptibility to localized vitiligo (show MITF Antibodies).

  8. HLA-A*24:02 is a common genetic risk factor for cutaneous adverse reactions induced by aromatic antiepileptic drugs in the southern Han Chinese and possibly other ethnic populations.

  9. the results support that a regulated assembly of these noncanonical HLA-I conformers during the immune response may enhance the avidity of their interaction with LILRB1 (show LILRB1 Antibodies).

  10. HLA-A*33:01 was associated with drug induced liver injury due to terbinafine and possibly fenofibrate and ticlopidine.

HLA-A Antigen Profile

Antigen Summary

HLA-A belongs to the HLA class I heavy chain paralogues. This class I molecule is a heterodimer consisting of a heavy chain and a light chain (beta-2 microglobulin). The heavy chain is anchored in the membrane. Class I molecules play a central role in the immune system by presenting peptides derived from the endoplasmic reticulum lumen. They are expressed in nearly all cells. The heavy chain is approximately 45 kDa and its gene contains 8 exons. Exon 1 encodes the leader peptide, exons 2 and 3 encode the alpha1 and alpha2 domains, which both bind the peptide, exon 4 encodes the alpha3 domain, exon 5 encodes the transmembrane region, and exons 6 and 7 encode the cytoplasmic tail. Polymorphisms within exon 2 and exon 3 are responsible for the peptide binding specificity of each class one molecule. Typing for these polymorphisms is routinely done for bone marrow and kidney transplantation. Hundreds of HLA-A alleles have been described.

Alternative names and synonyms associated with HLA-A

  • major histocompatibility complex, class I, A (HLA-A) antibody
  • HLAA antibody

Protein level used designations for HLA-A

HLA class I histocompatibility antigen, A-1 alpha chain , MHC class I antigen HLA-A heavy chain , antigen presenting molecule , leukocyte antigen class I-A

GENE ID SPECIES
3105 Homo sapiens
Selected quality suppliers for anti-HLA-A (HLA-A) Antibodies
Did you look for something else?